Spermidine: Autophagy, Longevity and Optimal Dosing

What Polyamines Do

Spermidine, spermine and putrescine are polyamines: small, positively charged molecules that bind nucleic acids and are essential for cell growth, translation and chromatin organisation. Every cell makes them, and their concentrations decline in most human tissues with age.

The functional consequence of that decline is not simply less growth signalling. Polyamines are required for the hypusination of eIF5A, a modification without which certain proteins, including the autophagy regulator TFEB, are translated inefficiently. As polyamine availability falls, autophagic capacity falls with it. That is the mechanistic thread connecting a small metabolite to the aging literature.

The Autophagy Mechanism

Autophagy is the process by which a cell encloses damaged components in a membrane and delivers them to the lysosome for breakdown and recycling. It is essential for mitochondrial quality control, for clearing aggregated proteins, and for surviving nutrient scarcity. Autophagic flux declines with age, and restoring it is one of the most consistent interventions in the animal longevity literature, whether achieved by caloric restriction, by fasting, by mTOR inhibition or pharmacologically.

Spermidine induces autophagy through at least two routes. It inhibits EP300, an acetyltransferase that suppresses autophagy proteins when active, so inhibiting it releases the brake. And by supporting eIF5A hypusination it improves translation of TFEB, the transcription factor that coordinates lysosomal and autophagy gene expression. Unlike rapamycin, spermidine achieves this without broadly suppressing mTOR signalling, which is one reason its side-effect profile is comparatively unremarkable.

Animal and Population Evidence

Model organisms

Spermidine supplementation extends lifespan in yeast, nematodes, flies and mice, and the effect is autophagy-dependent: genetically disabling autophagy abolishes it. In mice, cardiac work has reported improved diastolic function, reduced cardiac hypertrophy and improved mitochondrial function with spermidine in the drinking water. The cross-species consistency is unusual in this field.

Human population data

In a long-running Northern Italian population cohort, higher dietary spermidine intake was associated with lower all-cause mortality across two decades of follow-up, with the association surviving adjustment for the usual confounders. The reported difference between the highest and lowest intake groups was substantial in magnitude, comparable in scale to the difference associated with a several-year age gap. Observational data cannot establish causation, and people eating spermidine-rich diets differ in other ways, but the finding aligns with the mechanistic and animal work rather than contradicting it.

Human intervention trials

The intervention literature is thin. A trial in older adults with subjective cognitive decline using wheat germ extract delivering about 1.2 mg of spermidine per day reported a small improvement on a memory composite. A larger follow-up trial at a higher dose over twelve months found no significant benefit on its primary cognitive endpoint. Tolerability was good in both.

The honest summary: the mechanism is well characterised, the animal data are strong and consistent, the population association is notable, and the human intervention evidence has not yet delivered a robust functional result.

Dietary Sources Versus Supplements

Spermidine is one of the few longevity compounds where diet can plausibly deliver trial-level intakes. Concentrated sources include wheat germ, which is by a wide margin the richest common food, aged cheeses, natto and other fermented soy, mushrooms, legumes, and to a lesser extent whole grains and green vegetables.

A tablespoon of wheat germ contains a meaningful fraction of the intake used in the intervention trials. The gut microbiome also synthesises polyamines, so fibre intake and microbiome composition influence circulating spermidine independently of what appears on a food label. This is the rare case where the food-first argument is not merely rhetorical.

Supplements are typically wheat germ extracts standardised for spermidine content, delivering 1 mg to 10 mg per serving. Synthetic spermidine trihydrochloride is available but faces regulatory limits in several jurisdictions, and European novel food assessments have set intake limits based on the extract material rather than the isolated compound.

Dose, Timing and Fasting Interaction

• 1 to 1.2 mg per day. The dose in the first positive cognitive trial, from wheat germ extract.
• 3 to 6 mg per day. The range used in later and larger trials and in most commercial products.
• Above 6 mg per day. Beyond the range with human trial support, and beyond several regulatory intake assessments.

The timing question that actually matters is the interaction with fasting. Autophagy is suppressed by nutrient availability, particularly by amino acids and insulin signalling, so a spermidine dose taken with a substantial meal is being taken in the least favourable state. Taking it in a fasted window is mechanistically coherent, and while no human trial has compared timings directly, the reasoning costs nothing to follow.

Spermidine and fasting are complementary rather than redundant. Fasting removes the suppression on autophagy. Spermidine acts on the machinery itself. Combining them is more defensible than layering two compounds that hit the same node.

Safety and Who Should Be Careful

Spermidine from food sources has an unremarkable safety record, since human diets have always contained it. Trials using wheat germ extract report good tolerability with occasional mild gastrointestinal effects.

Two considerations deserve attention. Polyamine metabolism is upregulated in proliferating cells, and polyamine synthesis inhibitors have been investigated in oncology, which makes supplemental polyamine intake a question for anyone with an active or recent cancer history to discuss with their oncology team rather than decide alone. Separately, wheat germ extract is derived from wheat and is not appropriate for anyone avoiding gluten for medical reasons unless the specific product is verified gluten-free.

When to Reassess

Spermidine is a slow compound. It works, if it works, by improving a maintenance process whose output is not directly perceptible. There is no acute effect to feel, and expecting one leads people to abandon it prematurely or to escalate the dose pointlessly.

The sensible framing is a twelve-week minimum observation window with cognitive and energy measures noted at baseline, and a recognition that the population evidence describes intake sustained over decades rather than over a quarter. If a member is taking spermidine, the reassessment trigger is usually not "did I feel it" but a change in context: a new medication, a change in cancer history, a shift to a diet that already delivers the intake, or the arrival of better human trial evidence.